Your Catalyst To a Lucrative Business
The global Apheresis Equipment Market is categorized as per products, applications, procedures,
technologies, and geographies. According to products, the bifurcations are disposables and devices. In
revenue terms, devices held the highest share in 2013. Additionally, substantial revenues generated by this
segment can be attributed to the high prices of apheresis devices. The usage rate of disposable medical
devices is on the rise because they keep blood infections at bay and also lower the possibilities of hospital
acquired infections. These factors can stimulate overall industry performance till 2020.
Areas of product application are neurology, renal disease, hematology, and others. Neurology dominated the
industry in 2013 because of the frequent need for plasma exchanges and rising cases of multiple sclerosis in
the U.S. Use of apheresis equipment in neurology ensures shorter durations of treatment and lowers blood
loss. This segment is projected to expand remarkably in the forthcoming years.
On the basis of procedures, the overall industry is segmented into erythrocytapheresis, plateletpheresis,
plasmapheresis, leukapheresis, photopheresis, LDL-apheresis, and others. Owing to frequent applications in
the area of donor apheresis, plateletpheresis held the highest market share in 2013. However, photopheresis
was a rapidly expanding segment in the same year. There are two types of technologies, namely,
centrifugation and membrane filtration. In 2013, centrifugation held maximum industry shares. However, it is
anticipated that the membrane filtration segment will grow robustly over the next couple of years.
As per geographies, the worldwide apheresis equipment market is divided into North America, Europe, Asia
Pacific, and Rest of the World (RoW). North America dominated the global industry in 2013 because of
factors, such as technological advancements, widespread patient awareness, and supportive governmental
programs. Booming economies of the Asia Pacific, such as China and India may impel regional growth during
the forecast period. Key industry players are Terumo BCT Inc.; Hemacare Corporation; Therakos Inc.; Asahi
Kasei Kuraray Medical Co. Ltd.; and B. Braun Melsungen AG among others.
In 2016, a group of physicians examined the efficacy of lipoprotein apheresis therapy in the treatment
refractory angina. This therapy is normally used to remove excess cholesterol from the patient’s blood. Latest
results have however shown that unlike sham therapy (used for refractory angina), the extracorporeal
treatment proved more effective. Clinical trials have also revealed that lipoprotein apheresis helps reduce
angina symptoms and improve myocardial blood flow, exercise capacities, and overall quality of life.
Browse Related Category Market Reports @
https://www.hexaresearch.com/research-category/medical-devices-industry
Follow Us: